))
Interview with Jenni Davis: First Patient to Receive the Cleveland Clinic Breast Cancer Vaccine
Manage episode 362960988 series 2832919
Treść dostarczona przez Judy Fitzgerald. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Judy Fitzgerald lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
#Pinkvaccine #ClevelandClinicBreastCancerVaccine #TNBC #triplenegativebreastcancer #SurvivingBreastCancer #BreastCancerStory #BreastCancer #breastcancerawareness #SABCS #AARC #ASCO #PinkVaccine #Preventionisthecure #Sisters4Prevention #VincentTuohy
Jennifer Davis, 41, became the first person to get a breast cancer vaccine not yet approved for widespread use in a trial study in 2021.The vaccine had been in development at Cleveland Clinic for more than 20 years before it finally reached the human trial phase. Jenni Davis was a wife, mom of 3, daughter and registered nurse when she received the devastating diagnosis of Triple Negative Breast Cancer in 2018. She would complete treatment and surgeries and would qualify for the vaccine trial by a mere two weeks. This is her story of courage and faith in Dr. Tuohy's Science. The "Pink Vaccine" had been the dedicated work of the late Dr. Vincent Kevin Tuohy at the Lerner Research Institute of the Cleveland Clinic. It would take 20 years to get this vaccine from "Bench to Bedside" to test the hypothesis that "Prevention is the Cure". This is a story of perseverance, tenacity, faith and hope. The trial is ongoing under the direction of Dr. Justin Johnson who had worked with Dr. Touhy for 30 years on the vaccine project and Dr. Thomas Budd of the Taussig Cancer Center at the Cleveland Clinic.
53 odcinków
Udostępnij
